{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T21:52:57Z","timestamp":1793137977189,"version":"4.5.0"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiovascular Revascularization Medicine"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.carrev.2022.01.026","type":"journal-article","created":{"date-parts":[[2022,2,4]],"date-time":"2022-02-04T11:54:08Z","timestamp":1643975648000},"page":"166-169","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Gout Is Associated With Worse Post-PCI Long-Term Outcomes"],"prefix":"10.1016","volume":"41","author":[{"given":"Ofer","family":"Kobo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariel","family":"Roguin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Zukermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur","family":"Kerner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erez","family":"Marcusohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.carrev.2022.01.026_bb0005","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1111\/apt.15446","article-title":"Patients with inflammatory bowel disease have an increased risk of myocardial infarction: a nationwide study","volume":"50","author":"Choi","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.carrev.2022.01.026_bb0010","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1186\/ar2669","article-title":"Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases","volume":"11","author":"Gabriel","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.carrev.2022.01.026_bb0015","article-title":"THU0409 Not just a swollen big toe: increasing all-cause hospitalizations in patients with gout in the united states: 1993\u20132014","volume":"76","author":"Singh","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.carrev.2022.01.026_bb0020","first-page":"508","article-title":"Association of asymptomatic hyperuricemia with mortality in patients undergoing elective percutaneous coronary intervention","volume":"97","author":"Liu","year":"2017","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"10.1016\/j.carrev.2022.01.026_bb0025","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1136\/annrheumdis-2015-207719","article-title":"Outcomes of percutaneous coronary intervention in patients with rheumatoid arthritis and systemic lupus erythematosus: an 11-year nationwide cohort study","volume":"75","author":"Lai","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.carrev.2022.01.026_bb0030","first-page":"9","article-title":"Long-term clinical outcomes of patients with rheumatoid arthritis and concomitant coronary artery disease","volume":"7","author":"Spartera","year":"2017","journal-title":"Am J Cardiovasc Dis"},{"key":"10.1016\/j.carrev.2022.01.026_bb0035","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1161\/CIRCINTERVENTIONS.108.788745","article-title":"Poor 1-year outcomes after percutaneous coronary interventions in systemic lupus erythematosus: report from the National Heart, Lung, and Blood Institute dynamic registry","volume":"1","author":"Maksimowicz-McKinnon","year":"2008","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2022.01.026_bb0040","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.amjcard.2020.06.013","article-title":"Outcomes of percutaneous coronary intervention in patients with Crohn\u2019s disease and ulcerative colitis (from a Nationwide Cohort)","volume":"130","author":"Kobo","year":"2020","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.carrev.2022.01.026_bb0045","doi-asserted-by":"crossref","first-page":"137","DOI":"10.4330\/wjc.v11.i5.137","article-title":"Impact of gout on in-hospital outcomes of acute coronary syndrome-related hospitalizations and revascularizations: insights from the national inpatient sample","volume":"11","author":"Desai","year":"2019","journal-title":"World J Cardiol"},{"key":"10.1016\/j.carrev.2022.01.026_bb0050","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s13075-020-02175-2","article-title":"Gout is associated with an increased risk for incident heart failure among older adults: the REasons for geographic and racial differences in stroke (REGARDS) cohort study","volume":"22","author":"Colantonio","year":"2020","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.carrev.2022.01.026_bb0055","first-page":"778","article-title":"Long-term outcomes in patients with rheumatologic disorders undergoing percutaneous coronary intervention: a BAsel stent kosten-Effektivit\u00e4ts trial-PROspective validation examination (BASKET-PROVE) sub-study","volume":"6","author":"Nochioka","year":"2017","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"10.1016\/j.carrev.2022.01.026_bb0060","doi-asserted-by":"crossref","DOI":"10.5041\/RMMJ.10403","article-title":"Modern stents: where are we going?","volume":"11","author":"Kobo","year":"2020","journal-title":"Rambam Maimonides Med J"},{"key":"10.1016\/j.carrev.2022.01.026_bb0065","doi-asserted-by":"crossref","first-page":"535","DOI":"10.7326\/M18-1167","article-title":"Relationship of interleukin-1\u03b2 blockade with incident gout and serum uric acid levels: exploratory analysis of a randomized controlled trial","volume":"169","author":"Solomon","year":"2018","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.carrev.2022.01.026_bb0070","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.carrev.2022.01.026_bb0075","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1161\/CIRCULATIONAHA.118.033992","article-title":"Assessment of cardiovascular risk in older patients with gout initiating febuxostat versus allopurinol: population-based cohort study","volume":"138","author":"Zhang","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2022.01.026_bb0080","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1056\/NEJMoa1912388","article-title":"Efficacy and safety of low-dose colchicine after myocardial infarction","volume":"381","author":"Tardif","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.carrev.2022.01.026_bb0085","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1056\/NEJMoa2021372","article-title":"Colchicine in patients with chronic coronary disease","volume":"383","author":"Nidorf","year":"2020","journal-title":"N Engl J Med"}],"container-title":["Cardiovascular Revascularization Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838922000501?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838922000501?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:23:23Z","timestamp":1761560603000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1553838922000501"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":17,"alternative-id":["S1553838922000501"],"URL":"https:\/\/doi.org\/10.1016\/j.carrev.2022.01.026","relation":{},"ISSN":["1553-8389"],"issn-type":[{"value":"1553-8389","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gout Is Associated With Worse Post-PCI Long-Term Outcomes","name":"articletitle","label":"Article Title"},{"value":"Cardiovascular Revascularization Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.carrev.2022.01.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}